Last reviewed · How we verify
Supraventricular tachycardia
Approved treatments
- Brevibloc In Plastic Container · Pfizer
Brevibloc works by blocking the beta-1 adrenergic receptor, which reduces the heart's response to stress and increases heart rate. - Brevibloc · AOP Orphan Pharmaceuticals AG
- Onoact · Aop Hlth Us
Onoact works by blocking the beta-1 adrenergic receptor, which helps to slow down abnormal heart rhythms. - Inderal · Generic (originally ICI/AstraZeneca)
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Supraventricular tachycardia patent landscape — cliff calendar, originator estates, attackable patents
- Supraventricular tachycardia treatment landscape brief
- Supraventricular tachycardia treatment updates RSS
Frequently asked questions about Supraventricular tachycardia
What drugs treat Supraventricular tachycardia?
Tracked treatments include Brevibloc In Plastic Container, Brevibloc, Onoact, Inderal.
What is the treatment for Supraventricular tachycardia?
Standard treatment for Supraventricular tachycardia includes Brevibloc In Plastic Container, Brevibloc, Onoact, Inderal. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Supraventricular tachycardia patent cliff · Supraventricular tachycardia CI report
- Treatment: Brevibloc In Plastic Container · Pfizer
- Treatment: Brevibloc · AOP Orphan Pharmaceuticals AG
- Treatment: Onoact · Aop Hlth Us
- Treatment: Inderal · Generic (originally ICI/AstraZeneca)
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing